Can we stop colon cancer before it even begins?
In short: Colon cancer is a leading cause of cancer-related death globally, yet it is also one of the most preventable forms of the disease. Because the transformation from a small polyp to a cancerous growth often takes about ten years, there is a significant window for intervention and screening.
In the United States, colorectal cancer (CRC) ranks as the third most common malignant disease. While the diagnosis is serious, medical advancements in early detection and treatment are changing the landscape of survivorship. Currently, nearly two-thirds of CRC survivors live for at least five years following their initial diagnosis. This malignancy is currently the third most frequent type of cancer in the United States.
The increasing number of survivors presents a growing challenge for both oncology and primary care clinicians. As the U.S. population ages, the prevalence of CRC survivors is expected to increase dramatically. This demographic shift requires enhanced coordination between specialists and primary care doctors to manage long-term health risks effectively. Effective management relies heavily on seamless communication between oncologists and primary care providers. This coordination is vital for delivering risk-based healthcare to those who have finished active therapy.
Survivorship is seen as a spectrum comprising three separate stages: the time between diagnosis and finishing primary treatment, the shift toward extended survival, and long-term survival. Managing this transition is complex, as survivors face risks of cancer recurrence, the development of new primary cancers, and various physical or psychosocial side effects. Patients must be monitored for potential psychological, reproductive, or genetic concerns following their treatment.
These side effects can be categorized as long-term, persisting for months or years during treatment, or late effects, which may only emerge months or even years after the cancer and its therapy have concluded. Consequently, specialized guidelines are essential to help clinicians recognize these risks and maximize the quality of life for those in long-term survival. Clinicians must be properly equipped with resources to identify and handle these evolving health risks.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Who's at risk for colon cancer? - Amit H. Sachdev and Frank G. Gress
- Also: Who's at risk for colon cancer? - Amit H. Sachdev and Frank | TED-Ed
- Also: Amit H. Sachdev and Frank G. Gress: Who's at risk for colon cancer? | TED Talk
- Also: American Cancer Society Colorectal Cancer Survivorship Care Guidelines - PMC
To cite this card, link to https://intellectplus.co.uk/app/ideas-who-s-at-risk-for-colon-cancer-amit-h-sachdev-and-frank-g-gr.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
